Heart disease remains the leading cause of death in the United States, claiming nearly 700,000 lives each year, with many of these are due to secondary coronary events. But with proper cardiac rehabilitation, which can reduce risk of death by as much as 47%, many of those could likely have been avoided.
Tuesday, February 24, 2026
Sarasota Memorial’s Kolschowsky Research and Education Institute is part of an international clinical trial that may provide a new treatment option for those with advanced stage squamous cell skin cancer, one of the most common types of skin cancer, often found in areas exposed to the sun, such as the head, neck and arms. The Phase III study is evaluating whether adding an immunotherapy drug before surgery results in better outcomes, especially for those with fast-growing lesions that have a higher rate of recurrence or spreading to other parts of the body.
Tuesday, February 24, 2026
As American Heart Month comes to a close this week, Sarasota Memorial’s cardiac team is spotlighting the progress made – the rate of people dying from heart attacks has dropped nearly 90% – but also the work that remains: Despite decades of innovation, heart disease remains the #1 killer of both men and women, but now with arrhythmias, hypertension and heart failure making up the larger share of heart-related deaths.
Monday, February 23, 2026
Medical experts agree: Routine colorectal cancer screening should begin at age 45, not age 50 as guidelines previously advised. Sarasota Memorial gastroenterologist Stephen Kucera, MD, explains why and details screening options in this post.
Wednesday, February 18, 2026
An innovative study at Sarasota Memorial Hospital has found that interactive robotic pets can help hospitalized patients with dementia feel safer, more engaged and improve clinical outcomes. One of the first studies of its kind conducted in a hospital setting, the results highlight the value of using innovative, non-pharmacologic strategies to support dementia care.
Tuesday, February 17, 2026